2 min read

BRUNSWICK

Nineteen Mid Coast Hospital patients received injections prepared by a specialty pharmacy at the center of a nationwide meningitis outbreak.

Mid Coast did not purchase the steroid linked to the meningitis outbreak. “There is no evidence that these persons will become infected and we are not aware of any adverse safety concerns,” hospital officials said in a news release.

The hospital began notifying these patients the week of Oct. 22, “in order to be cautious and encourage them to be aware of signs and symptoms of infection,” it said.

Mid Coast is among dozens of Maine health organizations that received products from New England Compounding Center, which has been implicated in a deadly fungal meningitis outbreak.

Advertisement

Approximately 14,000 patients nationally may have been injected with a steroid containing the fungus. More than 300 people have been sickened and 23 have died from meningitis — a rare disease.

New England Compounding Center has suspended operations and all of its products have been recalled. To date, none of its other medications has been implicated in the outbreak.

The U.S. Food and Drug Administration on Wednesday released an updated list of about 3,000 hospitals, physician offices, health clinics and other organizations that were customers of the New England Compounding Center, based in Framingham, Mass.

The FDA withdrew its original list, which cited 14 medical facilities in Maine, after discovering inaccuracies. The updated list contains 34 facilities in Maine, though some are named twice.

Two health organizations that were included on the original list — Coastal Health and Skin Center in Ellsworth and the Well Woman Clinic in Freeport — were omitted from the revised list.

In the Mid-coast, Mid Coast and Miles Memorial Hospital of Damariscotta are on the list. A bit further out, Central Maine Medical Center and St. Mary’s Regional Medical Center, both of Lewiston, also are listed. So are several in Portland.

Advertisement

While these health facilities may have purchased products from the New England Compounding Center, FDA officials say the injectable steroid blamed in the meningitis outbreak was not used in Maine.

In fact, the state has recorded no cases of fungal meningitis, though health officials are monitoring 74 Maine residents who were treated in New Hampshire with the injections.

Other drugs made by the pharmacy have not been linked to illnesses. But the FDA, out of an abundance of caution, has recommended that patients who received the products be notified about the potential risk of infection.

St. Joseph Hospital in Bangor said it is participating in voluntary patient notification regarding products from the New England Compounding Center and that it has received and administered products from the company, but none that have been linked to the outbreak.

REPORTING by Times Record Staff Writer Larry Grard, Times Record Managing Editor Bob Mentzinger and Bangor Daily News reporter Jackie Farwell (bangordailynews.com) was used in this report.



Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.